FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

A.V. Fistula Needles Market Overview:

According to FutureWise analysis the market for A.V. fistula needles in 2023 is US$ 0.21 billion, and is expected to reach US$ 0.43 billion by 2031 at a CAGR of 9.56%.

An arteriovenous (AV) fistula needle is a specialized medical device used in haemodialysis, a life-saving treatment for individuals with kidney failure. The AV fistula is a surgically created connection between an artery and a vein in the patient's arm. It allows for the efficient removal and return of blood during the dialysis process. The AV fistula needle is specifically designed for accessing the AV fistula during haemodialysis sessions. It consists of a sharp needle attached to a tubing set. The needle is inserted into the AV fistula, allowing blood to be withdrawn from the patient's body and then returned after the dialysis machine has cleansed it.

The proper insertion of AV fistula needles is crucial to ensure successful haemodialysis treatments. Healthcare professionals undergo training to master the technique of needle insertion, aiming to minimize complications such as bleeding, infection, and damage to the AV fistula. Strict adherence to sterile techniques and aseptic procedures is essential to prevent infections and maintain the long-term viability of the AV fistula.

FutureWise Market Research has published a report that provides an insightful analysis of A.V. Fistula Needles Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the A.V. Fistula Needles Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

Major players included in the A.V. Fistula Needles Market:

Nipro
Fresenius
B. Braun
JMS
Kawasumi Lab
NxStage Medical
Asahi Kasei
Beldico
Farmasol
Hemoclean
Bain Medical
Tianjin Pharma
Hongda Medical
Far East Medical
Baihe Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

AV fistula needles are a necessity for a safe and effective means of accessing the AV fistula to perform hemodialysis. The AV fistula is contemplated the gold standard for vascular access in hemodialysis due to its superior long-term outcomes and lower risk of complications than other access methods, such as central venous catheters or arteriovenous grafts. AV fistula needles are designed with features allowing successful and comfortable needle insertion into the AV fistula. These features include sharp, beveled needles to penetrate the thickened vessel wall, appropriate needle lengths and gauges to accommodate different patient needs, and secure connection systems to ensure proper blood flow during dialysis. The above-mentioned factors are expected to drive the market growth. Moreover, manufacturers are continuously developing AV fistula needles with improved features, such as enhanced sharpness, bevel geometry, and needle tip configurations. These advancements aim to facilitate easier and more comfortable needle insertion into the AV fistula, minimizing pain and trauma for patients during the hemodialysis procedure. However, the risk of infection associated with AV fistula needles is expected to hinder market growth. Despite adherence to strict aseptic techniques, there is always a risk of introducing bacteria or other pathogens during needle insertion. Infections can lead to localized or systemic complications, requiring prompt medical attention and potential interruption of hemodialysis treatments, further restraining the market.

A.V. Fistula Needles Market Segmentation:

By Type

15 Gauge
16 Gauge
17 Gauge
Other

By Application

Dialysis Center
Home Dialysis
Other

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to well established healthcare system as well as awareness among individuals is driving the market growth in the region. Also, rising incidence of end stages renal disease along with rising ageing population in the region leading to haemodialysis is further driving the market growth in the region.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the A.V. Fistula Needles Market By Type, By Application and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1 . Years Considered for the Study
  3.2 . Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1 . Secondary Data
  1.1.1 . Key Data from Secondary Sources
  1.2 . Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. A.V. Fistula Needles Market Variables, Trends & Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Type Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Market Dynamics
      1.1. Market Driver Analysis
          1.1.1. Increasing focus of A.V. Fistula Needles Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
      1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
      1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
6. A.V. Fistula Needles Market Analysis Tools
- 1. Industry Analysis - Porter’s
      1.1. Supplier Power
      1.2. Buyer Power
      1.3. Substitution Threat
      1.4. Threat from New Entrants
      1.5. Competitive Rivalry
  2. Pestel Analysis
      2.1. Political Landscape
      2.2. Environmental Landscape
      2.3. Social Landscape
      2.4. Type Landscape
      2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
      3.1. Joint Ventures
      3.2. Mergers and Acquisitions
      3.3. Licensing and Partnership
      3.4. Type Collaborations
      3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. A.V. Fistula Needles Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
-     1. 15 Gauge
      2. 16 Gauge
      3. 17 Gauge
      4. Other
8. A.V. Fistula Needles Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
-     1. Dialysis Center
      2. Home Dialysis
      3. Other
9. North America A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
-     1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
          2.1. U.S.A
          2.2. Canada
          2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031
10. Latin America A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
-     1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
          2.1. Brazil
          2.2. Venezuela
          2.3. Argentina
          2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031
11. Europe A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
-     1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
          2.1. Germany
          2.2. U.K
          2.3. France
          2.4. Italy
          2.5. Spain
          2.6. Russia
          2.7. Poland
          2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031
12. Asia Pacific A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
-     1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
          2.1. Japan
        2.2. China
          2.3. India
          2.4. Australia and New Zealand
          2.5. ASEAN
          2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
13. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
-     1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
          2.1. Saudi Arabia
          2.2. UAE
          2.3. South Africa
          2.4. Egypt
      3. Market Size (USD Million) Forecast for MEA 2023-2031
14. Market Share Analysis and Competitive Landscape
-     1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
-       1. Nipro
          1.1. Company Overview
          1.2. Product Portfolio
          1.3. SWOT Analysis
          1.4. Financial Overview
          1.5. Strategic Overview
        2. Fresenius
          2.1. Company Overview
          2.2. Product Portfolio
          2.3. SWOT Analysis
          2.4. Financial Overview
          2.5. Strategic Overview
        3. B. Braun
          3.1. Company Overview
          3.2. Product Portfolio
          3.3. SWOT Analysis
          3.4. Financial Overview
          3.5. Strategic Overview
        4. JMS
          4.1. Company Overview
          4.2. Product Portfolio
          4.3. SWOT Analysis
          4.4. Financial Overview
          4.5. Strategic Overview
        5. Kawasumi Lab
          5.1. Company Overview
          5.2. Product Portfolio
          5.3. SWOT Analysis
          5.4. Financial Overview
          5.5. Strategic Overview
        6. NxStage Medical
          6.1. Company Overview
          6.2. Product Portfolio
          6.3. SWOT Analysis
          6.4. Financial Overview
          6.5. Strategic Overview
        7. Asahi Kasei
          7.1. Company Overview
          7.2. Product Portfolio
          7.3. SWOT Analysis
          7.4. Financial Overview
          7.5. Strategic Overview
        8. Beldico
          8.1. Company Overview
          8.2. Product Portfolio
          8.3. SWOT Analysis
          8.4. Financial Overview
          8.5. Strategic Overview
        9. Farmasol
          9.1. Company Overview
          9.2. Product Portfolio
          9.3. SWOT Analysis
          9.4. Financial Overview
          9.5. Strategic Overview
        10. Hemoclean
          10.1. Company Overview
          10.2. Product Portfolio
          10.3. SWOT Analysis
          10.4. Financial Overview
          10.5. Strategic Overview
        11. Bain Medical
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
        12. Tianjin Pharma
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
        13. Hongda Medical
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
        14. Far East Medical
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
        15. Baihe Medical
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
16. Pre and Post COVID-19 Impact
-     1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
- .

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients